Detalhe da pesquisa
1.
Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic.
Cell
; 186(5): 906-922, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36787743
2.
Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.
Cell
; 182(1): 7-9, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649880
3.
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.
Cell
; 181(4): 894-904.e9, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275855
4.
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS.
Cell
; 182(3): 722-733.e11, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645327
5.
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.
Cell
; 182(4): 828-842.e16, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645326
6.
Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
Cell
; 181(5): 969-977, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32437659
7.
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Cell
; 181(2): 281-292.e6, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32155444
8.
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Cell
; 181(2): 271-280.e8, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32142651
9.
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion.
Cell
; 176(5): 1026-1039.e15, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30712865
10.
Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes.
Immunity
; 55(12): 2419-2435.e10, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370711
11.
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability.
Immunity
; 54(12): 2908-2921.e6, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788600
12.
SARS-CoV-2: Combating Coronavirus Emergence.
Immunity
; 52(5): 734-736, 2020 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32392464
13.
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity.
Immunity
; 53(6): 1272-1280.e5, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33242394
14.
Lessons for COVID-19 Immunity from Other Coronavirus Infections.
Immunity
; 53(2): 248-263, 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32717182
15.
ACE2 binding is an ancestral and evolvable trait of sarbecoviruses.
Nature
; 603(7903): 913-918, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35114688
16.
Coronaviruses exploit a host cysteine-aspartic protease for replication.
Nature
; 609(7928): 785-792, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35922005
17.
T cells in COVID-19 - united in diversity.
Nat Immunol
; 21(11): 1307-1308, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32895541
18.
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
Nature
; 594(7862): 246-252, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845483
19.
DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner.
PLoS Biol
; 21(6): e3002097, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310920
20.
Potently neutralizing and protective human antibodies against SARS-CoV-2.
Nature
; 584(7821): 443-449, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668443